sujet home

WE FOCUS ENTIRELY ON DEVELOPING TUMOUR VACCINES

UTILISING THE ALL INDIVIDUALIZED PRECISION IMMUNOTHERAPY TUMOUR VACCINE TECHNOLOGY PLATFORM - AIPI

05/2026
Our CEO, Martin Munte, and Head of R&D and CMO, Ingrid Rauter, presented the establishment…
04/2026
Individualized cancer treatment starts with a clear ambition: therapies tailored to each patient. Discover…
02/2026
On February 26th, our Head of R&D, Ingrid Rauter, and CEO, Martin Munte, were pleased to attend…